EML4 (echinoderm microtubule associated protein like 4)

2009-07-01   Sven Perner  , Theresia Wilbertz  , Ann-Cathrin Stiedl  , Mark A Rubin  

Institute of Pathology, Comprehensive Cancer Center, University Hospitals of Tubingen, Tubingen, Germany (SP, TW, ACS); Department of Pathology, Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA (MAR)

Identity

HGNC
LOCATION
2p21
LOCUSID
ALIAS
C2orf2,ELP120,EMAP-4,EMAPL4,ROPP120
FUSION GENES

DNA/RNA

Atlas Image
2p with location of EML4 and ALK relative to each other.

Description

23 exons; DNA-length: 163,173 kb.

Transcription

Two transcript variants.

Proteins

Note

Strongly expressed during mitosis.
2 isoforms:
- Isoform a (= variant 1): longer transcript,
- Isoform b (= variant 2): shorter transcript, lacks an alternate in-frame exon.

Description

Weight: 120 kDa.
At least 2 Domains: HELP motif, WD40 repeat.
Exon 2 encodes for coiled-coil domain.

Expression

Ubiquitous.

Localisation

Intracellular.

Function

Microtubule binding.
Necessary for correct microtubule formation (stabilizes microtubules).
May modify the assembly dynamics of microtubules, such that microtubules are slightly longer, but more dynamic.

Homology

Mouse, rat.

Implicated in

Entity name
Non-small cell lung carcinoma (NSCLC)
Note
Mouse models suggest that EML4-ALK fusion might play an essential role in NSCLC carcinogenesis.
EML4-ALK-fusion-transcript is detectable in a low amount (frequency between 2,7% and 6,7%) of NSCLC-samples and NSCLC-cell-lines. So far, the fusion-protein could only be detected by mass-spectrometry. Immunohistochemical detection of the Alk-protein in fusion-transcript-positive primary NSCLC-samples is contentious.
Alk-inhibitors impede proliferation in EML4-ALK-fusion positive lung cancer cell-lines. In experiments with transgenic mice, treatment with ALK-inhibitors resulted in reduced tumor mass.
The role of EML4-ALK-fusion as a specific biomarker for NSCLC remains controversial.
Disease
NSCLC, frequency between 2,7% and 6,7%.
Prognosis
Controversially discussed. Limited informative because of low numbers studied so far.
Cytogenetics
EML4-ALK-Fusion. inv(2)(p21p23), other fusion-mechanisms suggested.
Hybrid gene
EML4-ALK.
Atlas Image
Fusion of EML4-ALK. a) wild type EML4 and ALK. b) fused EML4-ALK.
Fusion protein
EML4-ALK = tyrosine-kinase, which is constitutively dimerized and thus activated.
For known fusion partners of ALK, see ALK. For example, TPM3, TFG, MYH9, NPM, ATIC, MSN, ALO17 are ALK partners in anaplasic large cell lymphoma, CLTC in diffuse large cell lymphoma, and TPM4 in inflammatory myofibroblastic tumors.

Breakpoints

Atlas Image
EML4-ALK fusion isoforms (numbers = exon number).

Note

Known variants:
Variant 1: exon 1-13 (EML4) + exon 20-29 (ALK)
Variant 2: exon 1-20 (EML4) + exon 20-29 (ALK)
Variant 3a: exon 1-6a (EML4) + exon 20-29 (ALK)
Variant 3b: exon 1-6b (EML4) + exon 20-29 (ALK)
Variant 4a : exon 15 (EML4) + exon 20-29 (ALK)
Variant 4b : exon 14 (EML4) + linker of 11bp + exon 20-29 (ALK)
Variant 5a : exon 2 (EML4) + exon 20-29 (ALK)
Variant 5b : exon 2 (EML4) + intron 19 (ALK) + exon 20-29 (ALK)

Article Bibliography

Pubmed IDLast YearTitleAuthors
189235242008Oncogenic mutations of ALK kinase in neuroblastoma.Chen Y et al
185938922008Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.Choi YL et al
171963412007Echinoderm microtubule-associated protein like protein 4, a member of the echinoderm microtubule-associated protein family, stabilizes microtubules.Houtman SH et al
181668352008EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.Inamura K et al
185940102008EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.Koivunen JP et al
190323702008Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer.Mano H et al
191478282009EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues.Martelli MP et al
183200742008EML4-ALK fusion lung cancer: a rare acquired event.Perner S et al
168902222006Human EML4, a novel member of the EMAP family, is essential for microtubule formation.Pollmann M et al
176255702007Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.Soda M et al
190649152008A mouse model for EML4-ALK-positive lung cancer.Soda M et al
189273032008Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.Takeuchi K et al

Other Information

Locus ID:

NCBI: 27436
MIM: 607442
HGNC: 1316
Ensembl: ENSG00000143924

Variants:

dbSNP: 27436
ClinVar: 27436
TCGA: ENSG00000143924
COSMIC: EML4

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000143924ENST00000318522Q9HC35
ENSG00000143924ENST00000401738B5MBZ0
ENSG00000143924ENST00000402711Q9HC35

Expression (GTEx)

0
10
20
30
40
50
60

Pathways

PathwaySourceExternal ID
Non-small cell lung cancerKEGGko05223
Non-small cell lung cancerKEGGhsa05223

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA24719ALKGeneMultilinkAnnotationassociated25706305

References

Pubmed IDYearTitleCitations
347836002022The impact of the ALK fusion variant on clinical outcomes in EML4-ALK patients with NSCLC: a systematic review and meta-analysis.6
350747002022Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!3
347836002022The impact of the ALK fusion variant on clinical outcomes in EML4-ALK patients with NSCLC: a systematic review and meta-analysis.6
350747002022Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!3
328763292021Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma.3
337618962021EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells.3
343782832021An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma.2
343910652021Identification of a EML4-ALK exon 19 fusion variant in lung adenocarcinoma and alectinib resistance.4
344907272021A novel break site of EML4-ALK report and a rare PRKAR1A-ALK report analyzed by different ALK detection platforms in non-small cell lung cancer patients.3
346613672021Phase-separated foci of EML4-ALK facilitate signalling and depend upon an active kinase conformation.23
328763292021Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma.3
337618962021EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells.3
343782832021An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma.2
343910652021Identification of a EML4-ALK exon 19 fusion variant in lung adenocarcinoma and alectinib resistance.4
344907272021A novel break site of EML4-ALK report and a rare PRKAR1A-ALK report analyzed by different ALK detection platforms in non-small cell lung cancer patients.3

Citation

Sven Perner ; Theresia Wilbertz ; Ann-Cathrin Stiedl ; Mark A Rubin

EML4 (echinoderm microtubule associated protein like 4)

Atlas Genet Cytogenet Oncol Haematol. 2009-07-01

Online version: http://atlasgeneticsoncology.org/gene/44353/eml4-(echinoderm-microtubule-associated-protein-like-4)